Use of Real-World Data in Systematic Literature Reviews Conducted for Health Technology Assessment Submissions in Europe

被引：0
|
作者：
Dasari, G. [1 ]
Mulkalapalli, N. [2 ]
Bongale, A. A. [2 ]
Rajput, A. [3 ]
Kamra, S. [3 ]
Gaultney, J. [4 ]
机构：
[1] IQVIA, Hyderabad, AP, India
[2] IQVIA, Bangalore, AP, India
[3] IQVIA, Gurugram, India
[4] IQVIA, London, England
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA206
引用
收藏
页码：S337 / S337
页数：1
相关论文
共 50 条
  • [21] WHAT USE IS DISTRIBUTED LEDGER TECHNOLOGY IN REAL-WORLD PRACTICE? - A SYSTEMATIC LITERATURE REVIEW
    Abogunrin, S.
    Koufopoulou, M.
    Arregui, M.
    Lovelace, M.
    Arisa, O.
    VALUE IN HEALTH, 2018, 21 : S172 - S172
  • [22] The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment
    Cox, Oliver
    Sammon, Cormac
    Simpson, Alex
    Wasiak, Radek
    Ramagopalan, Sreeram
    Thorlund, Kristian
    VALUE IN HEALTH, 2022, 25 (07) : 1253 - 1256
  • [23] REAL-WORLD DATA TO SUPPORT SURROGATE ENDPOINT EVALUATION FOR HEALTH TECHNOLOGY ASSESSMENT
    Dupin, J.
    Thokagevistk, K.
    Emonnot, L.
    Micon, S.
    Benyounes, K.
    Haves, D.
    Civet, A.
    Pau, D.
    Le Dissez, C.
    Gally, S.
    Esnault, C.
    VALUE IN HEALTH, 2022, 25 (12) : S456 - S457
  • [24] Policy and practice: the role Real-World Data (RWD) in Health Technology Assessment
    de Waure, Chiara
    Petelos, Elena
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 217 - 217
  • [25] COMPARISON OF THE USE OF REAL-WORLD EVIDENCE (RWE) BY HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES IN REVIEWS OF DRUGS FOR RARE DISEASES (DRDS)
    Kirby, J.
    Tadros, N.
    Gosain, S.
    VALUE IN HEALTH, 2023, 26 (12) : S508 - S508
  • [26] A REVIEW OF REAL-WORLD EVIDENCE IN NON-ONCOLOGY SUBMISSIONS MADE TO FOUR HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES
    Balijepalli, C.
    Li, J.
    Ferrazzi, S.
    Mathers, E.
    Gullapalli, L.
    Awan, A.
    VALUE IN HEALTH, 2024, 27 (06) : S253 - S254
  • [27] Real-world evidence and nonrandomized data in health technology assessment: use existing methods to address unmeasured confounding?
    Sammon, Cormac J.
    Leahy, Thomas P.
    Gsteiger, Sandro
    Ramagopalan, Sreeram
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (14) : 969 - 972
  • [28] Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies
    Makady, Amr
    ten Ham, Renske
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    VALUE IN HEALTH, 2017, 20 (04) : 520 - 532
  • [29] Real-world evidence to support regulatory submissions: A landscape review and assessment of use cases
    Alipour-Haris, Golnoosh
    Liu, Xinyue
    Acha, Virginia
    Winterstein, Almut G.
    Burcu, Mehmet
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (08):
  • [30] Real-world use of ceftolozane/tazobactam: a systematic literature review
    Laura Puzniak
    Ryan Dillon
    Thomas Palmer
    Hannah Collings
    Ashley Enstone
    Antimicrobial Resistance & Infection Control, 10
12345